Search research articles
Contact Us
Filters
Showing results (81-90 of 350) with videos related to
Page
of 35
Sort By:
Cancer
|
January 15, 1992
Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia
M Talpaz, H Kantarjian, R Kurzrock, et al.
Hematology (Amsterdam, Netherlands)
|
July 15, 2016
Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management
F Ravandi-Kashani, J Cortes, H Kantarjian, et al.
Seminars in Hematology
|
January 1, 1988
Therapy of chronic myelogenous leukemia: chemotherapy and interferons
M Talpaz, H M Kantarjian, R Kurzrock, et al.
Cancer
|
June 22, 1999
Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
F Ravandi-Kashani, J Cortes, M Talpaz, et al.
Leukemia Research
|
January 1, 1995
Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia
M Wetzler, R Kurzrock, Z Estrov, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 26, 1999
A pilot study of recombinant human interleukin-4 therapy of myelofibrosis
F J Giles, A R Keating, R Kurzrock, et al.
The Journal of Laboratory and Clinical Medicine
|
April 2, 1998
Interleukin-1 increases expression of the LYT-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines
R Kurzrock, Z Estrov, S Ku, et al.
Clinical Immunology and Immunopathology
|
July 1, 1983
The immune restorative effect of Isoprinosine administration on the local graft-versus-host reaction of cancer patients
M Talpaz, W Wong, J Medina, et al.
Leukemia
|
May 1, 1996
Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors
A H Sarris, M Talpaz, A B Deisseroth, et al.
Experimental Hematology
|
August 1, 1986
Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients
M Talpaz, G Spitzer, W Hittelman, et al.
Page
of 35
Search research articles
Search
Showing results (81-90 of 350) with videos related to
Sort By:
Page
of 35
Cancer
|
January 15, 1992
Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia
M Talpaz, H Kantarjian, R Kurzrock, et al.
Hematology (Amsterdam, Netherlands)
|
July 15, 2016
Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management
F Ravandi-Kashani, J Cortes, H Kantarjian, et al.
Seminars in Hematology
|
January 1, 1988
Therapy of chronic myelogenous leukemia: chemotherapy and interferons
M Talpaz, H M Kantarjian, R Kurzrock, et al.
Cancer
|
June 22, 1999
Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
F Ravandi-Kashani, J Cortes, M Talpaz, et al.
Leukemia Research
|
January 1, 1995
Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia
M Wetzler, R Kurzrock, Z Estrov, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 26, 1999
A pilot study of recombinant human interleukin-4 therapy of myelofibrosis
F J Giles, A R Keating, R Kurzrock, et al.
The Journal of Laboratory and Clinical Medicine
|
April 2, 1998
Interleukin-1 increases expression of the LYT-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines
R Kurzrock, Z Estrov, S Ku, et al.
Clinical Immunology and Immunopathology
|
July 1, 1983
The immune restorative effect of Isoprinosine administration on the local graft-versus-host reaction of cancer patients
M Talpaz, W Wong, J Medina, et al.
Leukemia
|
May 1, 1996
Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors
A H Sarris, M Talpaz, A B Deisseroth, et al.
Experimental Hematology
|
August 1, 1986
Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients
M Talpaz, G Spitzer, W Hittelman, et al.
Page
of 35